Image may differ
AESKULISA®
Reference:
6052
Designation:
Varicella-Zoster Virus IgG
Intended use:

The AESKULISA® Varicella-Zoster Virus IgA, IgG and IgM tests are qualitative and quantitative immunoassays for the detection of human IgA, IgG and IgM antibodies in serum or plasma against Varicella-Zoster Virus. The AESKULISA® Varicella-Zoster Virus IgM supports the detection of acute infections. The AESKULISA® Varicella-Zoster Virus IgG allows the confirmation of pathogen contact and supports the determination of the immune status. The AESKULISA® Varicella-Zoster Virus IgA is used in particular to detect reactivations. The AESKULISA® Varicella-Zoster Virus IgA and AESKULISA® Varicella-Zoster Virus IgG are also used to detect intrathecally produced antibodies in cerebrospinal fluid. The interpretation of the results can only be made in connection with the clinical picture. A diagnosis should not be based solely on the results of the test performed, but should always be made taking into account all clinical and laboratory findings. Further tests should be carried out for confirmation. AESKULISA® immunoassays are suitable for use by healthcare professionals with appropriate professional training in the use of in vitro diagnostics.

Method:
ELISA
Conjugate:
IgG
Analysis:
Qualitative
,
Quantitative
Cut Off:
Cut-off control
Measurement range:
Kit-specific
QC certificate
Calibration:
WHO W1044
Provisions:
1 x 96
Kit-Configuration:
Single
Number of antigens:
1
Registration:
CE marking
Coated Antigens:
Glycoproteins of the varicella zoster virus
Ellen strain
AESKULISA®

6052

Varicella-Zoster Virus IgG

Image may differ
Intended use:

The AESKULISA® Varicella-Zoster Virus IgA, IgG and IgM tests are qualitative and quantitative immunoassays for the detection of human IgA, IgG and IgM antibodies in serum or plasma against Varicella-Zoster Virus. The AESKULISA® Varicella-Zoster Virus IgM supports the detection of acute infections. The AESKULISA® Varicella-Zoster Virus IgG allows the confirmation of pathogen contact and supports the determination of the immune status. The AESKULISA® Varicella-Zoster Virus IgA is used in particular to detect reactivations. The AESKULISA® Varicella-Zoster Virus IgA and AESKULISA® Varicella-Zoster Virus IgG are also used to detect intrathecally produced antibodies in cerebrospinal fluid. The interpretation of the results can only be made in connection with the clinical picture. A diagnosis should not be based solely on the results of the test performed, but should always be made taking into account all clinical and laboratory findings. Further tests should be carried out for confirmation. AESKULISA® immunoassays are suitable for use by healthcare professionals with appropriate professional training in the use of in vitro diagnostics.

Method:
ELISA
Conjugate:
IgG
Analysis:
Qualitative
,
Quantitative
Cut Off:
Cut-off control
Measurement range:
Kit-specific
QC certificate
Calibration:
WHO W1044
Provisions:
1 x 96
Kit-Configuration:
Single
Number of antigens:
1
Registration:
CE marking
Coated Antigens:
Glycoproteins of the varicella zoster virus
Ellen strain
Downloads
All related documents and information clearly summarized

Instructions for Use

Safety Data Sheet